Skip to main content

24.04.2019 | Hepatobiliary Tumors | Ausgabe 8/2019

Annals of Surgical Oncology 8/2019

Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma

Annals of Surgical Oncology > Ausgabe 8/2019
MD, PhD Liang-Shuo Hu, MD, PhD Xu-Feng Zhang, MD Matthew Weiss, MD Irinel Popescu, MD Hugo P. Marques, MD Luca Aldrighetti, MD Shishir K. Maithel, MD Carlo Pulitano, MD Todd W. Bauer, MD Feng Shen, MD George A. Poultsides, MD Oliver Soubrane, MD Guillaume Martel, MD B. Groot Koerkamp, MD Endo Itaru, MD, MPH, PhD, FACS, FRACS (Hon) Timothy M. Pawlik
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1245/​s10434-019-07353-4) contains supplementary material, which is available to authorized users.
Liang-Shuo Hu and Xu-Feng Zhang have contributed equally to this study.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.



Recurrence of intrahepatic cholangiocarcinoma (ICC) after curative resection is common.


The aim of this study was to investigate the patterns, timing and risk factors of disease recurrence after curative-intent resection for ICC.


Patients undergoing curative resection for ICC were identified from a multi-institutional database. Data on clinicopathological and initial operation information, timing and first sites of recurrence, recurrence management, and long-term outcomes were analyzed.


A total of 920 patients were included. With a median follow-up of 38 months, 607 patients (66.0%) experienced ICC recurrence. In the cohort, 145 patients (23.9%) recurred at the surgical margin, 178 (29.3%) recurred within the liver away from the surgical margin, 90 (14.8%) recurred at extraheptatic sites, and 194 (32.0%) developed both intrahepatic and extrahepatic recurrence. Intrahepatic margin recurrence (median 6.0 m) and extrahepatic-only recurrence (median 8.0 m) tended to occur early, while intrahepatic recurrence at non-margin sites occurred later (median 14.0 m; p < 0.05). On multivariate analysis, surgical margin < 10 mm was associated with increased margin recurrence (hazard ratio [HR] 1.70, 95% confidence interval [CI] 1.11–2.60; p = 0.014), whereas female sex (HR 2.12, 95% CI 1.40–3.22; p < 0.001) and liver cirrhosis (HR 2.36, 95% CI 1.31–4.25; p = 0.004) were both associated with an increased risk of intrahepatic recurrence at other sites. Median survival after recurrence was better among patients who underwent repeat curative-intent surgery (48.7 months) versus other treatments (9.7 months) [p < 0.001].


Different recurrence patterns and timing of recurrence suggest biological heterogeneity of ICC tumor recurrence. Understanding timing and risk factors associated with different types of recurrence can hopefully inform discussions around adjuvant therapy, surveillance, and treatment of recurrent disease.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Jetzt e.Med bestellen und 100 € sparen!

Weitere Produktempfehlungen anzeigen
Über diesen Artikel

Weitere Artikel der Ausgabe 8/2019

Annals of Surgical Oncology 8/2019 Zur Ausgabe

Health Services Research and Global Oncology

Changing Trends in Industry Funding for Surgical Oncologists

  1. Sie können e.Med Chirurgie 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Chirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Chirurgie und bleiben Sie gut informiert – ganz bequem per eMail.